Search
Now showing items 1-8 of 8
Serum galectin-3 and TGF-beta levels in patients with sarcoidosis
(2020)
Introduction: Sarcoidosis is a chronic granulomatous disease that develops with non-caseified granuloma formation. Galectin-3 is a multifunctional protein operating in biological processes such as fibrosis, angiogenesis, ...
Concomitant autoimmune diseases in patients with sarcoidosis in Turkey
(Turkish League Against Rheumatism, 2020)
Objectives: This study aims to determine the frequency and characteristics of autoimmune diseases associated with sarcoidosis patients. Patients and methods: The study included 131 sarcoidosis patients (36 males, 95 females; ...
Secukinumab-induced Raynaud's phenomenon: first report in the literature
(Sage Publications Ltd, 2020)
Secukinumab is an IL-17A antagonist that has proven efficacy in the treatment of patients with ankylosing spondylitis (AS) and psoriatic arthritis. Side effects of the drug include infections, skin rashes, and allergic ...
Regression of sarcoidosis during pregnancy: case report and review of the literature
(2020)
Sarcoidosis is a chronic granulomatous disease characterized by non-caseating granuloma formation. It usually involves the lung, but may also affects many organs and systems such as the musculoskeletal system, eye, skin, ...
Secukinumab in a patient with sarcoidosis
(Taylor and Francis Ltd, 2020)
Sarcoidosis is a systemic granulomatous disease, characterized by non-caseating granuloma formation. It
usually involves the lungs, but may also affect the
eyes, heart, skin, and musculoskeletal system. The
pathogenesis ...
Comment on "Colchicine may not be effective in COVID-19 infection; it may even be harmful?"
(Springer London Ltd, 2020)
We read with great interest the report by Cure et al. which speculated
that colchicine may not be effective in COVID-19 infection
[1]. The main argument of the authors is that colchicine may
have not increased the ...
Elderly - onset sarcoidosis: a single center comparative study
(Ediciones Doyma, S.L., 2020)
Objectives: Sarcoidosis rarely affect patients older than 65 years old. The purpose of this study is to compare and evaluate the demographic, clinical and laboratory features of elderly-onset (EOS) and young-onset sarcoidosis ...
Catch the rainbow: prognostic factor of sarcoidosis
(2020)
Sarcoidosis is a systemic, chronic, inflammatory disease characterized by noncaseating granuloma formations. The fact that the etiopathogenesis of the disease has not been elucidated yet brings it many theories and ...